Clinical Trial Update: Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the long-term safety and efficacy of ABX464 in active ulcerative colitis and has completed with results posted on 2025-03-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ABX464 (ABX464)

Snippet

Sponsor: Abivax S.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2025-03-05